UCB SA(UCB.BR)— 技術面狀態
數據截至2026-11-02 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades +26.6% vs the 50-day and +15% vs the 200-day average, 3.5% below the 52-week high and +40.8% off the 52-week low; a death cross printed 60 sessions ago. Computed from daily closes.
移動平均線狀態
- 相對20日均線+19.8%
- 相對50日均線+26.6%
- 相對200日均線+15%
- 52週區間低於52週高點3.5% · 高於52週低點40.8%
- 連續走勢連續1個交易日下跌
- 均線交叉死亡交叉(60個交易日前)
- 50日均線交叉股價向上穿越50日均線(9個交易日前)
- 隨機指標%K 94.1 · %D 96.1(死亡交叉)
相關頁面: UCB.BR圖表與概覽 · 品質與財務體檢 · 訊號看板
FAQ · from the current data · as of 2026-11-02
Quick answers
UCB.BR目前的Closelook訊號是什麼?
Recovery attempt under the 200-day — Trades +26.6% vs the 50-day and +15% vs the 200-day average, 3.5% below the 52-week high and +40.8% off the 52-week low; a death cross printed 60 sessions ago. Computed from daily closes.(截至2026-11-02;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
UCB.BR目前是否位於50日與200日均線上方?
截至2026-11-02,UCB SA位於50日均線上方(+26.6%),200日均線上方(+15%);距20日均線+19.8%。
UCB.BR距52週高點有多遠?
截至2026-11-02,低於52週高點3.5%,高於52週低點40.8%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- REGN Regeneron Pharmaceuticals Incindustry
- RIGL Rigel Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- EXEL Exelixis Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- VRDN Viridian Therapeutics Incindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- BHVN Biohaven Ltd.industry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- KYMR Kymera Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- ADMA ADMA Biologics Incindustry
- IRON Disc Medicine Inc.industry